Research location

Beijing

China

Published trials1,717

Site observations3,054

Linked trials published1,717

Page1 / 35

Research activity in Beijing

China

CureCurrent currently publishes aggregate city-level research activity for this location: 1,717 trials and 3,054 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Beijing

1,717 linked trials · page 1 of 35

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseaseNCT07717411 · 2026-11-30 · 1 site observation

PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial HypertensionNCT07852403 · 2026-10-01 · 1 site observation

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyNCT07039474 · 2026-09-08 · 1 site observation

A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study ParticipantsNCT07784699 · 2026-09-02 · 1 site observation

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNCT07776509 · 2026-08-24 · 1 site observation

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 10 site observations

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's DiseaseNCT07737743 · 2026-08-24 · 2 site observations

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusNCT07775404 · 2026-08-21 · 3 site observations

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightNCT07784270 · 2026-08-20 · 1 site observation

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusNCT07784725 · 2026-08-19 · 1 site observation

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderNCT07775300 · 2026-08-14 · 1 site observation

Barriers and Facilitators of Persistence With Adjuvant OsimertinibNCT07542210 · 2026-08-13 · 1 site observation

Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection FractionNCT07693049 · 2026-08-10 · 10 site observations

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)NCT07759245 · 2026-08-07 · 1 site observation

A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLCNCT07586202 · 2026-07-28 · 1 site observation

A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic BronchitisNCT07725939 · 2026-07-27 · 1 site observation

VG081821AC Tablets for Early to Mid-stage Parkinson's DiseaseNCT07725562 · 2026-07-17 · 1 site observation

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenNCT07621809 · 2026-07-16 · 1 site observation

Timing of ctDNA Testing in Advanced Breast CancerNCT07681323 · 2026-07-08 · 1 site observation

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusNCT07662109 · 2026-07-06 · 3 site observations

A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesNCT07670416 · 2026-07-03 · 1 site observation

Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in ChinaNCT07593248 · 2026-06-22 · 1 site observation

A Study of DA-302168S in Participants With Overweight/ObesityNCT07629544 · 2026-06-19 · 1 site observation

A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)NCT07619820 · 2026-06-17 · 1 site observation

Risk Factor Assessment for Acute Pulmonary Hypertension CrisisNCT07653958 · 2026-06-17 · 1 site observation

Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical StudyNCT07637877 · 2026-06-15 · 1 site observation

Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma DiagnosisNCT07516184 · 2026-06-10 · 1 site observation

hUC-MSC-Exosomes for T2DM - Safety & EfficacyNCT07693036 · 2026-06-05 · 1 site observation

A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)NCT07613424 · 2026-06-02 · 1 site observation

Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt)NCT07614724 · 2026-06-02 · 1 site observation

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's DiseaseNCT07457125 · 2026-05-30 · 1 site observation

Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.NCT07279935 · 2026-05-26 · 3 site observations

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-PositiveNCT07413939 · 2026-05-21 · 3 site observations

Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With HypertensionNCT07607275 · 2026-05-15 · 4 site observations

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)NCT07611110 · 2026-05-04 · 2 site observations

Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC ImmunotherapyNCT07668037 · 2026-05-01 · 1 site observation

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With ObesityNCT07633639 · 2026-05-01 · 1 site observation

Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung DiseaseNCT07843381 · 2026-05-01 · 1 site observation

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's DiseaseNCT07571161 · 2026-04-30 · 1 site observation

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderNCT07573176 · 2026-04-30 · 1 site observation

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in ChinaNCT07316062 · 2026-04-29 · 1 site observation

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NECNCT07416695 · 2026-04-17 · 1 site observation

FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart FailureNCT07657650 · 2026-04-10 · 1 site observation

Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental IllnessNCT07571226 · 2026-04-10 · 1 site observation

Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 DiabetesNCT07527078 · 2026-04-07 · 1 site observation

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)NCT07416474 · 2026-04-03 · 1 site observation

Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm StudyNCT07295821 · 2026-04-01 · 2 site observations

Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerNCT07329322 · 2026-03-30 · 1 site observation

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23 · 2 site observations

Radiotherapy After Prostatectomy for Node Positive Prostate CancerNCT07477626 · 2026-03-20 · 4 site observations

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.